Identifying specific protein interaction partners using quantitative mass spectrometry and bead proteomes by Trinkle-Mulcahy, Laura et al.
T
H
E
J
O
U
R
N
A
L
O
F
C
E
L
L
B
I
O
L
O
G
Y
JCB: ARTICLE
The Rockefeller University Press    $30.00
J. Cell Biol. Vol. 183 No. 2  223–239
www.jcb.org/cgi/doi/10.1083/jcb.200805092 JCB 223
  Correspondence to Laura Trinkle-Mulcahy: ltrinkle@uottawa.ca; or Angus 
Lamond:   angus@lifesci.dundee.ac.uk   
  Abbreviations used in this paper: FP, ﬂ  uorescent protein; SILAC, stable isotope 
labeling with amino acids in cell culture. 
    The online version of this article contains supplemental material.     
        Introduction 
  Most biological processes involve the action and regulation of 
multiprotein complexes. In many cases, separate properties 
such as subcellular localization, catalytic activity, and substrate 
specifi  city are determined by different polypeptides in a holo-
enzyme complex, and specifi  c protein interaction partners may 
be present in nonstoichiometric amounts. For example, catalytic 
subunits such as protein phosphatase 1 (PP1) can interact with a 
spectrum of alternative protein partners, which thus bind non-
stoichiometrically to generate a range of holoenzymes with dif-
ferent specifi  cities (for review see   Moorhead et al., 2007  ). This 
can make it diffi  cult to distinguish specifi  c but low abundance 
interacting proteins from the larger number of low affi  nity, but 
abundant, contaminant proteins that are inevitably recovered 
using commonly used methods such as pull-down or immuno-
precipitation strategies. A key goal in most areas of cell biology, 
therefore, is the characterization of the protein components of 
multiprotein complexes through the reliable identifi  cation of 
specifi  c protein interaction partners. 
  Any putative interaction partner identifi  ed either through 
affi  nity purifi  cation or biochemical fractionation must be vali-
dated to confi  rm its physiological relevance. These downstream 
validation experiments, involving detailed molecular character-
ization, are both costly and time consuming and thus it is 
imperative to focus resources on those subsets of potential inter-
actions with a high probability of biological signifi  cance. Con-
tinuing improvement in the sensitivity and resolution of the 
mass spectrometric technology for protein identifi  cation, for ex-
ample, allows for the identifi  cation of ever larger numbers of 
proteins in immunoaffi  nity and pull-down experiments. In addi-
tion to bona fi  de interaction partners, however, these expanding 
lists include increased numbers of contaminant proteins, including 
those that bind nonspecifi  cally to the affi  nity matrix. The prob-
lem of nonspecifi  c binding cannot be overcome satisfactorily 
T
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we present a reliable afﬁ  nity puriﬁ  cation strategy 
to identify speciﬁ  c interactors that combines quantitative 
SILAC-based mass spectrometry with characterization 
of common contaminants binding to afﬁ   nity matrices 
(bead proteomes). This strategy can be applied to afﬁ  nity 
puriﬁ   cation of either tagged fusion protein complexes 
or endogenous protein complexes, illustrated here using 
the well-characterized SMN complex as a model. GFP is 
used as the tag of choice because it shows minimal non-
speciﬁ   c binding to mammalian cell proteins, can be 
quantitatively depleted from cell extracts, and allows the 
integration of biochemical protein interaction data with 
in vivo measurements using ﬂ   uorescence microscopy. 
Proteins binding nonspeciﬁ  cally to the most commonly 
used afﬁ  nity matrices were determined using quantitative 
mass spectrometry, revealing important differences that 
affect experimental design. These data provide a speci-
ﬁ  city ﬁ  lter to distinguish speciﬁ  c protein binding partners 
in both quantitative and nonquantitative pull-down and 
immunoprecipitation experiments.
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 In summary, we present here a powerful and reliable workfl  ow 
that can be applied to analyze affi  nity-purifi  ed protein com-
plexes isolated using either tagged fusion proteins or via immuno-
precipitation of endogenous proteins. 
  Results 
  Optimized workﬂ  ow for quantitative 
analysis of endogenous and tagged protein 
complexes 
 A  standard  workfl  ow for SILAC-based analysis of protein inter-
action partners in pull-down experiments is summarized in   Fig. 1  . 
In brief, the total protein components isolated from either an 
immunoprecipitation or affi  nity pull-down experiment are size 
fractionated using SDS-PAGE. The gel is cut into typically 5  –  10 
slices, each of which is digested with trypsin and the resulting 
peptides eluted and analyzed by high sensitivity mass spectrom-
etry (see Materials and methods). 
  The procedures described show the optimized protocols 
we have derived from over 50 separate interaction analyses. 
This is applied routinely for the analysis of interaction partners 
binding to fl  uorescent protein (FP)  –  tagged fusion proteins in 
whole cell, cytoplasmic, and nuclear extracts (  Fig. 1 A  ). Cells 
expressing the tagged protein are grown in   “  heavy  ”   media, i.e., 
containing  
13  C-substituted arginine and lysine. As a control, ei-
ther parental/untransfected cells or cells expressing free GFP are 
grown in   “  light  ”  , i.e., unlabeled ( 
12  C) media. Initially, cell lines 
expressing free GFP were routinely used as a control. However, 
experience showed that the level of nonspecifi  c protein binding 
to free GFP in mammalian cell lines was so low that nonexpress-
ing cells can also provide a suitable negative control. 
  In this approach the negative   “  light  ”   control and the experi-
mental  “ heavy ”  sample are mixed before mass spectrometric analy-
sis. This reduces the effective experimental variability that inevitably 
results when the samples are processed independently. Here   extracts 
mixed before the GFP immunoprecipitation step were analyzed. 
However, separate immunoprecipitations can also be performed 
and the affi  nity matrices mixed before eluting proteins for further 
analysis. Specifi  c steps in the protocol can be optimized according 
to the specifi  c requirements of individual experiments. However, it 
is recommended that the duration of incubation for the binding step 
to the affi  nity matrix is always minimized, to reduce potential losses 
of dynamic or weakly associated factors. The present protocol 
has been optimized using extracts from HeLa and U2OS cells. 
Analysis using extracts from other cell lines should be optimized 
individually to ensure effi  cient protein recovery. 
  A similar SILAC strategy can also be applied for the anal-
ysis of protein interaction partners recovered from direct immuno-
precipitation of endogenous complexes (  Fig. 1 B  ). In this case, 
a control must be performed with a nonspecifi  c antibody, e.g., 
either preimmune IgG, or an antibody raised against a tag or epi-
tope that is not expressed in these cells. Because separate, parallel 
immunoprecipitations are required for the control and test sam-
ples, care must be taken when mixing the beads to ensure that 
equal quantities of material are compared. 
  An important issue for maximizing the identifi  cation of 
protein interaction partners is ensuring both effi  cient isolation of 
using high stringency purifi  cation methods; although this can 
reduce the level of nonspecifi  c binding, it will inevitably also 
remove low abundance and low affi  nity specifi  c partner pro-
teins. The most effective strategy must therefore preserve all 
specifi  c interaction events, which inevitably results in a large 
number of nonspecifi  c proteins also copurifying that must be 
identifi  ed and discarded. 
  To solve this problem, we and others have demonstrated 
that a quantitative mass spectrometry  –  based approach combined 
with isotope labeling can help to distinguish which of the many 
proteins identifi  ed in a pull-down or immunoprecipitation ex-
periment represent specifi  c binding. This is done by the inclusion 
of a negative control, which provides a background of contaminant 
proteins that bind nonspecifi  cally to the affi  nity matrix and/or 
the fusion tag, against which proteins that bind specifi  cally to 
the protein of interest clearly stand out (for review see   Vermeulen 
et al., 2008  ). For example, using a combination of stable isotope 
labeling with amino acids in cell culture (SILAC)  –  based quan-
titative proteomics (  Ong et al., 2002  ) with immunoprecipitation 
of GFP-tagged fusion proteins, we revealed differences in bind-
ing partners for two different isoforms of the nuclear protein 
phosphatase, PP1 (  Trinkle-Mulcahy et al., 2006  ). Other groups 
have used a similar approach based on tagged bait proteins to 
map the spectrum of human 26S proteasome interacting proteins 
(  Wang and Huang, 2008  ) and to detect dynamic members of 
transcription factor complexes (  Mousson et al., 2008  ). Isotope-
based quantitative approaches have also been used to defi  ne 
tagged protein complexes in yeast (  Ranish et al., 2003  ;   Tackett 
et al., 2005 ) and both tagged and endogenous protein complexes 
in mammalian cells (  Blagoev et al., 2003  ;   Cristea et al., 2005  ; 
  Selbach and Mann, 2006  ). 
  Although the isotope labeling strategy used in a SILAC 
affi  nity purifi  cation approach provides great help in separating 
specifi  c from nonspecifi  c interactors, experience shows that not 
all specifi  c interactions can be unambiguously determined, par-
ticularly near the threshold level where signal-to-noise ratios 
are close to background. Here we describe a new SILAC-based 
mass spectrometry strategy that specifi  cally addresses this issue, 
incorporating methods to increase the signal, i.e., the abundance 
of purifi  ed protein complexes, while reducing or fi  ltering out 
the noise, i.e., proteins that bind nonspecifi  cally to the affi  nity 
matrix, tag, and/or antibody. 
 The effi  ciency of detecting interaction partners relies upon 
effi  cient depletion of the targeted complex. Here we show that 
GFP-tagged proteins can be near quantitatively depleted using 
the recently developed GFP binder (  Rothbauer et al., 2008  ). 
The GFP binder is an   Escherichia coli  – expressed  16-kD  protein 
derived from a llama heavy chain antibody that binds with high 
affi  nity and specifi  city to GFP. This underlines the utility of us-
ing GFP as a dual tag for both affi  nity purifi  cation and in vivo 
fl  uorescence microscopy. Furthermore, characterizing the pro-
teins that bind nonspecifi  cally to three of the most commonly 
used affi  nity matrices, in either whole cell, nuclear, or cyto-
plasmic extracts of mammalian cells, provides a   “  bead proteome ”  
fi  lter. This facilitates distinguishing specifi  c from nonspecifi  c 
binding proteins and thereby allows objective prioritization of 
suitable targets for detailed molecular characterization. 225 IDENTIFYING SPECIFIC PROTEIN INTERACTION PARTNERS   • Trinkle-Mulcahy et al. 
of potential GFP-interacting proteins that should be considered 
as possible contaminants when identifi  ed in any interaction 
analysis of a GFP-tagged protein. However, none of these puta-
tive contaminants were recovered in all four experiments and 
most are also identifi  ed as proteins that bind nonspecifi  cally to 
affi  nity matrices (see below). Consistent with the FRAP data, it 
was observed in the extracts tested that there are no major con-
taminating proteins that copurify reproducibly with free GFP. 
However, attention is drawn to six proteins, specifi  cally variants 
of heat shock 70-kD protein, cytokeratins 8 and 18, and ubiqui-
tin, which were most frequently detected as copurifying with 
GFP-tagged fusion proteins (  Fig. 2 C  ). It is possible that these 
proteins, which all bind nonspecifi  cally to the Sepharose matrix, 
are not binding GFP directly but are instead up-regulated in the 
cell line overexpressing GFP. In summary, the SILAC data dem-
onstrate that GFP, despite its size of 27 kD, is an effective tag 
for use in pull-down experiments. It shows low levels of non-
specifi  c interactions and can be quantitatively depleted from 
cell extracts using the GFP binder. 
  Characterization of Sepharose bead 
proteome 
  Next, a systematic assessment was made of which proteins in 
cell extracts bind nonspecifi  cally to the Sepharose matrix, which 
the target protein under study and achieving a high signal-to-noise 
ratio. In the case of FP-tagged proteins, our results show this is 
best achieved using the recently developed GFP binder (  Rothbauer 
et al., 2008  ), which reproducibly provides near-quantitative de-
pletion of GFP fusion proteins (  Fig. 2  ). Direct comparison with 
commercially available anti-GFP monoclonal antibodies (mAbs) 
shows that an affi  nity matrix coupled to the GFP binder routinely 
produces higher depletion effi  ciencies and improves signal-to-
noise ratios (  Fig. 2, A and B  ; and unpublished data). 
  GFP is a 27-kD protein, and a tag of this size could poten-
tially bind itself to a range of cell proteins. We note that in vivo 
FRAP measurements in both the cytoplasm and nucleus show 
that photobleaching GFP expressed in live cells results in rapid 
recovery (Fig. S1, available at http://www.jcb.org/cgi/content/
full/jcb.200805092/DC1). This indicates that GFP in vivo pre-
dominantly diffuses as a free protein and therefore binds weakly 
or not at all with most cellular protein complexes. Nonetheless, 
a subset of GFP molecules could still associate with cell pro-
teins, and it is also possible that this could increase upon cell 
fractionation. To test this more rigorously, the SILAC pull-down 
method was used to analyze directly which proteins in mamma-
lian cell extracts copurify with GFP isolated using either the 
GFP binder or a commercially available anti-GFP mAb (  Fig. 2 C  ). 
Data from four independent experiments generated a short list 
  Figure 1.       Protocols used for SILAC-based analysis of protein interaction partners in pull-down experiments.   (A) HeLa cells expressing a GFP-tagged 
protein are metabolically labeled by culturing in   “  heavy  ”   media containing  
13  C-isotopes of arginine and lysine, while the parental HeLa cells are grown 
in   “  light  ”   media containing the  
12  C-isotopes of arginine and lysine. Whole cell extracts can be prepared or, as shown here, cells can be fractionated for 
preparation of separate cytoplasmic and nuclear extracts. In this case, extracts are pre-cleared on Sepharose beads and then mixed in equal amounts 
before afﬁ  nity puriﬁ  cation of the GFP-tagged protein using the GFP binder (1 h incubation). Proteins are eluted from the beads and separated by 1D SDS-
PAGE for digestion and LC-MS/MS analysis. (B) For SILAC analysis of an endogenous protein, two populations of HeLa cells are grown in light and heavy 
media, respectively, before harvesting and preparation of cellular extracts. Equal total protein amounts of each extract are subjected to separate immuno-
afﬁ  nity experiments, either using an antibody to the protein of interest or a control antibody covalently bound to beads at an equivalent concentration. The 
separate immunoprecipitates are mixed carefully to minimize variability and the proteins eluted and analyzed as described above.     JCB • VOLUME 183 • NUMBER 2 • 2008  226
GFP fusion proteins in either whole cell, cytoplasmic, or nu-
clear extracts prepared from HeLa and U2OS cells using stan-
dard RIPA buffer (see Materials and methods). Analysis of the 
combined dataset reveals a wide range of cellular proteins that 
has been used routinely in pull-down experiments and with the GFP 
binder (  Tables I and II  ). We defi  ne the set of proteins binding to 
the affi  nity matrix as a   “  bead proteome.  ”   Data were pooled from 
27 independent SILAC pull-down experiments on 11 separate 
  Figure 2.       GFP as a tag in immunoafﬁ  nity experiments.   Although a commercial monoclonal anti-GFP antibody is capable of isolating signiﬁ  cant amounts 
of free GFP from a stable HeLa cell line, the GFP binder is more efﬁ  cient, as demonstrated both by Coomassie staining of protein eluted from the afﬁ  nity 
matrices (A) and Western blotting using anti-GFP antibodies (B). Whether the mAb or GFP binder is used to purify GFP, there are very few proteins that bind 
nonspeciﬁ  cally to this tag (C). Four independent experiments were performed to identify proteins that may copurify with GFP, as indicated by SILAC ratios 
greater than 1 (IP1: whole cell extract, GFP binder; IP2: whole cell extract, monoclonal anti-GFP antibody; IP3: cytoplasmic extract, monoclonal anti-GFP 
antibody; IP4: nuclear extract, monoclonal anti-GFP antibody). No one protein was identiﬁ  ed in every experiment, and most of them (in bold) have been 
identiﬁ  ed as binding nonspeciﬁ  cally to the Sepharose bead matrix. This list was then screened against a set of 18 independent GFP protein immunoafﬁ  nity 
experiments performed using the GFP binder for puriﬁ  cation and parental cells as the negative control. Proteins were scored for the percentage of experi-
ments in which they were detected (yellow), and for the percentage of experiments in which they were detected and showed a SILAC ratio greater than 
1 (green). Six proteins, representing three protein classes (heat shock/chaperone, cytokeratin, and ubiquitin), have been highlighted in green as the most 
frequently detected and potentially able to bind GFP.     227 IDENTIFYING SPECIFIC PROTEIN INTERACTION PARTNERS   • Trinkle-Mulcahy et al. 
teins in nuclear extracts as compared with Sepharose. In contrast, 
Sepharose, which showed more nonspecifi  c interactions with 
nucleic acid  –  binding factors, gave better results than magnetic 
beads in reducing nonspecifi  c background in cytoplasmic ex-
tracts (  Fig. 3 C  ; Table S1, available at http://www.jcb.org/cgi/
content/full/jcb.200805092/DC1). In the case of agarose beads, 
similar levels of nonspecifi  c binding to Sepharose were ob-
served in nuclear extracts, whereas agarose beads showed lower 
nonspecifi  c binding in cytoplasmic extracts as compared with 
either Sepharose or magnetic beads (Fig. S2, available at http://
www.jcb.org/cgi/content/full/jcb.200805092/DC1). Overall, it can 
be concluded that the affi  nity matrices constitute a major source 
of nonspecifi  c protein binding for all protein interaction studies 
and the detailed data obtained from comparing the three main 
types of affi  nity matrices show that no single type of bead is 
ideally suited to all applications. Rather, improved results with 
respect to nonspecifi  c protein binding can be obtained by using 
different types of affi  nity matrix depending upon whether pro-
tein interaction studies are performed using cytoplasmic or nu-
clear extracts, or other types of cellular fractions. 
  Application of SILAC strategy to identify 
protein interaction partners 
 Having identifi  ed parameters affecting nonspecifi  c protein binding, 
the optimized workfl  ow described above was tested for the analysis 
of a previously characterized multiprotein complex. As a model 
system, we selected for analysis the intensively studied and well-
characterized SMN complex. SMN is the product of the major hu-
man gene responsible for the inherited genetic disorder spinal 
muscular atrophy (for review see  Kolb et al., 2007 ) and is known to 
form a complex with multiple specifi  c partner proteins, including 
gemins and snRNP proteins (see   Table III   and references therein). 
  Because SMN is found in multiprotein complexes in both 
the nucleus and the cytoplasm (  Fig. 4 A  ), and because some of 
its previously identifi  ed interactions were reported to be com-
partment specifi  c (  Fig. 4 B  ), we fractionated cells into nuclear 
and cytoplasmic extracts to compare the interaction partners iden-
tifi  ed by SILAC in both compartments. A HeLa cell line stably 
expressing GFP-SMN (  Sleeman et al., 2003  ) was grown in media 
containing  
13  C-labeled arginine and lysine, with parental HeLa 
cells grown in normal  
12  C-labeled media as a negative control. 
The cells were harvested and fractionated into cytoplasmic and 
nuclear extracts, pull-down experiments were performed using the 
GFP binder, and proteins were analyzed by mass spectrometry. 
This resulted in identifi  cation of over 20 proteins previously de-
scribed to copurify with SMN. The average SILAC ratio and 
number of peptides identifi  ed for each protein in both cytoplasmic 
and nuclear extracts is listed in   Table III  . 
  To facilitate identifi  cation of specifi  c binding partners, we 
used a data analysis approach that incorporated both SILAC ra-
tios (i.e.,  
13 C: 
12  C peptide ratios) and relative peptide abundance 
(  Fig. 4, C and D  ). These data plotting log SILAC ratios versus 
total peptide intensity show that SMN itself and the known core 
members of the SMN protein complex (e.g., gemins 2  –  8, shown 
in yellow in   Fig. 4, C and D  ) are readily identifi  ed. 
  These data also show that p80 coilin, which was previously 
shown to interact with SMN specifi  cally in the nucleus, was here 
routinely bind to the Sepharose matrix and which therefore 
must be regarded as potential nonspecifi  c contaminants when-
ever they are identifi  ed in protein interaction studies. These in-
clude histones, hnRNP proteins, heat shock proteins, ribosomal 
proteins, translation and initiation factors, DEAD box proteins, 
and multiple cytoskeletal proteins ( Table I ). Over 100 additional 
proteins of other classes were also identifi  ed (  Table II  ). These 
common matrix-binding contaminants have therefore been in-
corporated into a fi  lter set that can be used to compare with sets 
of proteins identifi  ed as potential specifi  c interaction partners 
for any target protein under study. 
  Comparison of Sepharose, agarose, and 
magnetic bead proteomes 
  Using the SILAC protocol, a comparison was made of non-
specifi  c protein binding to Sepharose as compared with two other 
commonly used affi  nity matrices, i.e., agarose and magnetic 
beads (  Fig. 3  ). In this case, labeling was conducted using three 
isotopic states, i.e.,  
12 C-arg  and   
12  C-lys for agarose,  
13 C-arg  and 
D4-lys for Sepharose, and  
13 C/ 
15 N-arg  and   
13 C/ 
15 N-lys  for  mag-
netic beads. Nonspecifi  c protein binding was observed for all 
three matrices after incubation of either nuclear or cytoplasmic 
extracts, whether the incubation time was short (30 min) or long 
(18 h). At both the short and long time points, a similar distribu-
tion of classes of contaminating proteins was observed, although 
the levels of protein binding can increase after longer incuba-
tion. An interesting difference was apparent in the relative per-
formance of Sepharose and magnetic beads when incubated 
with either nuclear or cytoplasmic extracts. Thus, magnetic beads, 
which showed more nonspecifi  c binding to structural/motility 
protein classes and lower nonspecifi  c binding to nucleic acid  –
  binding factors, had lower backgrounds of contaminating pro-
  Table I.   Sepharose bead proteome: most common protein classes   
Protein class Most commonly found
Cytoskeletal/structural/ 
 motility  proteins
Actin
Coﬁ  lin
Desmin
Desmoplakin
Epiplakin
Filamin
Myosin
Peripherin
Plectin
Tropomyosin
Tubulin
Vimentin
DEAD box proteins
Eukaryotic translation elongation 
and initiation factors
Heat shock proteins
Histones
hnRNP proteins
Ribosomal proteins
Proteins that bind nonspeciﬁ  cally to Sepharose fall into several distinct classes, 
as shown here, and are found in nearly every SILAC immunoprecipitation ex-
periment carried out using Sepharose as an afﬁ  nity matrix.JCB • VOLUME 183 • NUMBER 2 • 2008  228
  Table II.   Sepharose bead proteome: other proteins of additional classes   
   Gene Name    Description NP CP WC
  % Exp.    % Exp.    % Exp. 
ADAR Double-stranded RNA-speciﬁ  c adenosine deaminase 54.5 0.0 11.1
AHNAK AHNAK nucleoprotein isoform 1 54.5 28.6 55.6
ALB Albumin 100.0 45.5 57.1
ANXA1, 2 Annexin 1, A2 100.0 100.0 77.8
ASCC3L1 Activating signal co-integrator 1 complex subunit 3-like 1 63.6 0.0 22.2
ASS1 Argininosuccinate synthase 0.0 57.1 55.6
ATAD ATPase family, AAA domain containing protein 27.3 0.0 22.2
ATP5A, 5B ATP synthase, H+ transporting, mitochondrial F1 complex 81.8 14.3 77.8
BAG2 BCL2-associated athanogene 2 27.3 0.0 11.1
BOLA2B BolA-like protein 2B 22.2 36.4 28.6
CAD Carbamoylphosphate synthetase 2 0.0 85.7 33.3
CAND1 Cullin-associated NEDD8-dissociated protein 1 9.1 28.6 33.3
CAPRIN1 Cytoplasmic activation- and proliferation-associated protein 1 33.3 45.5 0
CCT Chaperonin containing TCP1 45.5 28.6 55.6
CD180 Elongation factor 1-alpha 45.5 57.1 33.3
CFL1 Coﬁ  lin 63.6 85.7 66.7
CHD3, D4 Chromodomain-helicase-DNA-binding protein 3, 4 18.2 0.0 11.1
CLEC2D C-type lectin domain family 2, member D 36.4 0.0 0.0
CLTC Cathrin heavy chain 1 36.4 85.7 77.8
COPA, B1 Coatomer protein complex, subunits A, B1 18.2 28.6 44.4
CORO1C Coronin, actin binding protein 1C 66.7 27.3 14.3
CPS1 Carbamoyl-phosphate synthetase 1 54.5 71.4 44.4
CRKL Crk-like protein 22.2 9.1 28.6
CSDA Cold shock domain-containing protein A 55.6 36.4 71.4
CSRP2 Cysteine and glycine-rich protein 2 54.5 28.6 11.1
DBN1 Drebrin 1 (developmentally regulated brain protein) 66.7 36.4 28.6
DHRS2 Dehydrogenase/reductase (SDR family) member 2 36.4 14.3 22.2
DUT dUTP pyrophosphatase 22.2 18.2 14.3
DYNLL1 Dynein light chain 1 27.3 28.6 11.1
EDARRAD EDAR-associated death domain 9.1 0.0 66.7
ELAVL1 ELAV-like 1 63.6 0.0 22.2
EMD Emerin 36.4 28.6 0.0
ENO Enolase 1 9.1 14.3 77.8
EWSR1 Ewing sarcoma breakpoint region 1 27.3 14.3 33.3
FARSA,B,FASN Phenylalanyl-tRNA synthetase; Fatty acid synthase 36.4 85.7 88.9
FBL Fibrillarin 63.6 14.3 22.2
FKSG30 FKSG30 36.4 57.1 66.7
FUS Fus-like protein 36.4 14.3 33.3
G3BP1,2 GTPase activating protein (SH3 domain) binding protein 1, 2 44.4 18.2 14.3
G6PD Glucose-6-phosphate 1-dehydrogenase 9.1 28.6 22.2
GAPDH Glyceraldehyde-3-phosphate dehydrogenase 18.2 42.9 55.6
GFAP Glial ﬁ  brillary acidic protein 36.4 42.9 55.6
GNAS Guanine nucleotide-binding protein G 22.2 9.1 14.3
GNB2L1 Guanine nucleotide binding protein (G protein), beta polypeptide 2-like 1 36.4 28.6 44.4
GNL2,3 Guanine nucleotide-binding protein-like 2 (nucleolar) 100 0 0
GSR Glutathione reductase 36.4 42.9 33.3
GSTM3 Glutathione S-transferase M3 18.2 28.6 22.2
ILF 2, 3 Interleukin enhancer binding factor 2, 3 54.5 42.9 55.6
KHDRBS1,2,3 KH domain containing, RNA binding, signal transduction associated 45.5 0.0 11.1
KHSRP Far upstream element-binding protein 2 36.4 0.0 11.1
KIF2,4 Kinesin family member 2, 4 44.4 36.4 14.3
LDHA Lactate dehydrogenase A 9.1 42.9 55.6
LGALS1,3 Beta-galactoside  –  binding lectin 72.7 57.1 55.6
LIMA1 LIM domain and actin-binding protein 1 44.4 9.1 14.3
LMNA, B Lamin A/C, B 90.9 0.0 33.3
MATR3 Matrin 3 63.6 0.0 44.4229 IDENTIFYING SPECIFIC PROTEIN INTERACTION PARTNERS   • Trinkle-Mulcahy et al. 
  Table II.   Sepharose bead proteome: other proteins of additional classes   (Continued) 
   Gene Name    Description NP CP WC
  % Exp.    % Exp.    % Exp. 
MCM3,5 Minichromosome maintenance complex component 3, 5 54.5 14.3 44.4
MIF Macrophage migration inhibitory factor 9.1 28.6 22.2
MSH2 MutS protein homologue 2 77.8 0 14.3
MTCH2 Mitochondrial carrier homologue 2 36.4 0.0 11.1
NACA Nascent polypeptide-associated complex subunit alpha 11.1 18.2 14.3
NCL Nucleolin 72.7 42.9 22.2
NES Nestin 55.6 9.1 14.3
NME1, 2 Non-metastatic cells protein 1, 2 18.2 28.6 11.1
NONO Non-POU domain containing, octamer-binding 36.4 0.0 11.1
NPM1 Nucleophosmin 1 81.8 0.0 44.4
NUDT16L1 Nudix (nucleoside diphosphate linked moiety X)-type motif 16-like 1 77.8 0 14.3
NUMA1 Nuclear mitotic apparatus protein 1 66.7 18.2 42.9
NUP155 Nucleoporin 155 kD 54.5 0.0 11.1
PABPC1,3,4 Poly(A) binding protein, cytoplasmic 1, 3, 4 18.2 57.1 33.3
PALLD Palladin, cytoskeletal associated protein 45.5 0.0 11.1
PARK7 DJ-1 protein 36.4 28.6 44.4
PARP1 Poly (ADP-ribose) polymerase family, member 1 27.3 0.0 11.1
PCBP1, 2 Poly(rC)-binding protein 1, 2 63.6 85.7 55.6
PCMT Protein-  L  -isoaspartate(  D  -aspartate)   O  -methyltransferase 18.2 57.1 33.3
PDIA6 Protein disulﬁ  de-isomerase A6 63.6 14.3 77.8
PDLIM2,4 PDZ and LIM domain protein 2 55.6 0 0
PFDN2 Prefoldin subunit 2 9.1 14.3 11.1
PFN2 Proﬁ  lin 2 36.4 28.6 33.3
PHB, PHB2 Prohibitin, prohibitin 2 63.6 42.9 77.8
PHF5A PHD ﬁ  nger protein 5A 45.5 0.0 11.1
PHGDH Phosphoglycerate dehydrogenase 18.2 71.4 44.4
PKM2 Pyruvate kinase, muscle 54.5 71.4 66.7
POTE2 Protein expressed in prostate, ovary, testis, and placenta 2 54.5 42.9 66.7
PPIA Peptidylprolyl isomerase A (cyclophilin A) 66.7 27.3 71.4
PRDX1,2,3,4 Peroxiredoxin 1, 2, 3, 4 90.9 71.4 100.0
PRKDC Protein kinase, DNA-activated 81.8 14.3 44.4
PTBP1,2 Polypyrimidine tract-binding protein 1, 2 63.6 14.3 11.1
RALY RNA-binding protein (autoantigenic, hnRNP-associated with lethal, yellow) 100 27.3 28.6
RCC2 Regulator of chromosome condensation 2 63.6 0.0 11.1
S100A6,9,10,14 S100 calcium binding protein A 100 36.4 42.9
SAP18 Sin3-associated polypeptide, 18 kD 44.4 0 14.3
SEC61B Protein transport protein Sec61 beta subunit 45.5 0.0 11.1
SERBP1 SERPINE1 mRNA binding protein 1 45.5 0.0 22.2
SERPINH1,A11 Serine (or cysteine) proteinase inhibitor 72.7 28.6 66.7
SF3B Splicing factor 3B 54.5 0.0 22.2
SLC25A ADP/ATP translocase 2 (solute carrier family 25) 100.0 71.4 100.0
THOC4 THO complex subunit 4 44.4 9.1 0
TKT Transketolase 36.4 42.9 33.3
TMPO Thymopoietin 22.2 0 28.6
TOMM22 Translocase of outer membrane 22-kD subunit homologue 22.2 0 28.6
TRAP1 Tumor necrosis factor type 1 receptor-associated protein (heat shock protein 75) 44.4 27.3 42.9
TRIM21 52-kD Ro protein 18.2 28.6 33.3
TRIM25 Tripartite motif-containing protein 25 (Zinc ﬁ  nger protein 147) 18.2 0.0 0.0
TTBK2 Tau-tubulin kinase 18.2 14.3 44.4
TUFM Tu translation elongation factor, mitochondrial 63.6 14.3 55.6
TXN Thioredoxin 27.3 57.1 55.6
U2AF1 U2 small nuclear RNA auxillary factor 1 27.3 0.0 11.1
UBA52 Ubiquitin and ribosomal protein L40 precursor 36.4 57.1 55.6
UBE2D2,3 Ubiquitin-conjugating enzyme E2D 2, E2D 3 18.2 14.3 0.0
UQCRC1 Ubiquinol-cytochrome   c   reductase core protein I 63.6 0.0 22.2JCB • VOLUME 183 • NUMBER 2 • 2008  230
lute value of the SILAC ratios. Although under ideal conditions 
a ratio of 1 should be obtained for nonspecifi  c binding, this ab-
solute value can vary experimentally in either direction. This is 
illustrated in   Fig. 5 A  , where the absolute peak values for the 
bell-shaped curves for the separate nuclear and cytoplasmic ex-
tracts differ slightly. Within each experiment, the SILAC ratios 
can thus be evaluated with respect to the actual background ra-
tio curve determined and a corresponding threshold set for that 
experiment (  Fig. 5 A  , hashed blue and red lines). 
  To further extend this analysis and improve confi  dence, 
the bead proteome data are next applied as a fi  lter to highlight 
proteins that are known to bind nonspecifi  cally to the affi  nity 
matrix and reveal proteins that may bind specifi  cally yet are close 
to or below the chosen threshold. As illustrated for the cytoplas-
mic extract, SILAC ratios are fi  rst plotted for all proteins previ-
ously identifi  ed as binding nonspecifi  cally to Sepharose (  Fig. 5 B  ). 
Proteins that may bind to the GFP tag itself (  Fig. 2 C  ) are also 
included in this list (  Fig. 5 B  , green). In the case of hnRNP pro-
teins, which are commonly found in the Sepharose bead pro-
teome, multiple members of the hnRNP family seen in the analysis 
of SMN-associated proteins are identifi  ed as likely contaminants 
with SILAC ratios at or below the threshold level. However, 
hnRNP U alone stands out with a higher SILAC ratio in both 
nuclear and cytoplasmic experiments, consistent with previous 
evidence reporting hnRNP U as a specifi  c component of the SMN 
complex (  Liu and Dreyfuss, 1996  ). This demonstrates that not 
all proteins in the bead proteome are inevitably binding non-
specifi  cally and therefore they should not be excluded on this 
basis alone from further analysis. 
  Although the majority of potential contaminants have 
SILAC ratios either at or near the chosen threshold, some 
show signifi  cantly higher ratios, such as desmin and transketo-
lase. This is either due to a real interaction with GFP-SMN, or 
to variability inherent in the experiment or in the quantitation. 
Importantly, by highlighting these proteins as potential con-
taminants, they may be considered lower priority for future 
detailed analysis. 
 Next,  fi  ltering out proteins known to bind nonspecifi  -
cally to Sepharose leaves a list of putative interacting partners 
that can also be analyzed separately (  Fig. 5 C  ). As shown 
here, over two-thirds of these proteins have a SILAC ratio 
also found by SILAC as a specifi  c interaction partner only in nu-
clear extract ( Fig. 4 D  and  Table III ). Furthermore, the cytoplasm-
specifi  c interaction partner PRMT5 was also found here as a 
specifi  c interaction partner only in cytoplasmic extract (  Fig. 4 C   
and   Table III  ). These results demonstrate the effectiveness of the 
SILAC approach for identifying specifi  c protein binding partners 
and show that it can resolve compartment-specifi  c interactions. 
  Almost all of the other previously reported SMN inter-
action partners were also found in this analysis (see   Table III  ), 
although in some cases the SILAC ratios were close to those for 
nonspecifi  c Sepharose-binding contaminant proteins. The anal-
ysis of the SMN complex thus illustrates the importance of in-
cluding information from additional data to the SILAC ratios, 
including peptide abundance and bead proteome information, 
to help distinguish specifi  city where SILAC ratios are close to 
background levels. For example, both PRMT5 and Unrip, which 
have been reported to interact with SMN, show relatively low 
SILAC ratios compared with the gemins. However, the fact that 
neither of these proteins was detected binding nonspecifi  cally to 
either GFP or Sepharose increases the probability that they are 
specifi  c binders. In contrast, certain proteins with higher SILAC 
ratios, such as desmin and transketolase, were commonly found 
in the Sepharose bead proteome, which reduces the probability 
that they represent specifi  c binding partners for SMN. Peptides 
were also found for hnRNP Q and RNA helicase A, both re-
ported to interact with SMN (  Mourelatos et al., 2001  ;   Pellizzoni 
et al., 2001b  ;   Rossoll et al., 2002  ). The peptides were not quan-
tifi  able, however, and we therefore did not include them in the 
list of unambiguously identifi  ed known SMN interaction part-
ners. Interestingly, U1 70k protein was found to copurify with 
GFP-SMN from cytoplasmic extracts, with 15 separate peptides 
detected with high SILAC ratios. SMN was reported to bind the 
U1 snRNA and the U1 snRNP-specifi  c A protein, although this 
interaction with the U1-specifi  c 70k protein was not previously 
detected (  Pellizzoni et al., 2002b  ). 
  We have developed a useful strategy for analyzing the 
SILAC data to help distinguish specifi  c interactions (  Fig. 5  ). 
Data acquired from SILAC-based quantitative immunoprecipi-
tation experiments are fi  rst plotted in a histogram. This helps to 
visualize the grouping of nonspecifi  c binding proteins, which 
generally fall within a bell-shaped curve regardless of the abso-
  Table II.   Sepharose bead proteome: other proteins of additional classes   (Continued) 
   Gene Name    Description NP CP WC
  % Exp.    % Exp.    % Exp. 
VAPA/B VAMP (vesicle-associated membrane protein)-associated protein A, B 44.4 27.3 28.6
VCP Valosin-containing protein 44.4 18.2 42.9
VDAC2,3 Voltage-dependent anion channel 2, 3 63.6 0.0 22.2
XPO1 Exportin 1 9.1 0.0 22.2
XRCC5, 6 ATP-dependent DNA helicase II 18.2 14.3 0.0
YBX1 Y box binding protein 1 36.4 28.6 33.3
YWHAZ,YWHAB Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein 27.3 28.6 44.4
In addition to the common classes of proteins listed in Table I, there are over 100 proteins, shown here, that do not fall into these speciﬁ  c classes yet still bind Sepharose 
nonspeciﬁ  cally. This list was screened against datasets from 27 independent SILAC immunoprecipitation experiments using either nucleoplasmic (NP; 11 experiments), 
cytoplasmic (CP; 7 experiments), or whole cell (WC; 9 experiments) extracts to determine the frequency of detection and distribution of these nonspeciﬁ  c binding 
proteins among these distinct cellular extracts. The frequency is listed as the percentage of experiments in which the protein was detected.231 IDENTIFYING SPECIFIC PROTEIN INTERACTION PARTNERS   • Trinkle-Mulcahy et al. 
with GFP binder from both cytoplasmic and nuclear extracts 
(  Fig. 6  ). In this case, cells expressing free GFP were used as a 
control. An antibody specifi  c to USP9X detected specifi  c pull-
down of USP9X by GFP-SMN, especially in the cytoplasmic 
extracts (  Fig. 6 A  ). This confi  rms the identifi  cation of USP9X 
in the previous SILAC experiments, and is consistent with the 
fact that USP9X peptides were only identifi  ed by SILAC in the 
cytoplasmic extract (for an example of a mass spectrum for 
a USP9X SILAC peptide, see  Fig. 6 B ). The predominantly cyto-
plasmic signal of USP9X is also consistent with immuno-
fl  uorescence analysis. Thus, immunostaining of HeLa cells with 
anti-USP9X antibody revealed that it is enriched in the cyto-
plasm, although a weak nucleoplasmic pool is also detected 
(  Fig. 6 C  ). The localization of endogenous USP9X is the same 
in the presence (bottom cell) and absence (top cell) of GFP-SMN, 
and in both cases there is no apparent accumulation in gems. 
The fact that USP9X had not been identifi  ed previously as asso-
ciating with this well-characterized protein complex suggests 
that it may either be low abundance, interact transiently with the 
SMN complex, and/or bind with low affi  nity. 
 As a positive control, Western blotting was also performed 
to confi  rm the enrichment of SMN and U1A under the same 
suffi  ciently high to indicate specifi  c interaction with GFP-SMN, 
and indeed most are known SMN interaction partners, as de-
tailed in   Table III  . Of the remaining proteins, several are 
known SMN interacting partners that, in this experiment, have 
SILAC ratios close to threshold and thus may have been over-
looked in the initial analysis (e.g., Sm proteins, PRMT5, and 
Unrip). This emphasizes the importance of the enhanced work-
fl  ow for highlighting specifi  c interaction partners among a sea 
of contaminants. 
  Most of the remaining proteins shown in   Fig. 5 C   have 
low SILAC ratios and correspond to metabolic enzymes, which 
at this stage appear as low priority targets for further analysis. 
However, one of the remaining novel proteins identifi  ed here, 
USP9X, had a higher SILAC ratio (  Fig. 5 C  ) and is known to be 
a de-ubiquitinating enzyme that was recently shown to regulate 
AMPK-related kinases (  Al-Hakim et al., 2008  ). We therefore 
selected this as the highest priority for follow up analysis. 
  Validation of USP9X by Western blotting 
  To test whether the identifi  cation of USP9X by SILAC analysis 
can be verifi  ed by an independent method, we next performed 
Western blotting analysis on protein complexes affi  nity purifi  ed 
  Figure 3.       Comparison of bead proteomes.   (A) Design of the SILAC immunoprecipitation experiment used to compare the bead proteomes of agarose, 
Sepharose, and magnetic beads. For all three, the protein G  –  conjugated versions were used. The experiment was performed in two stages, ﬁ  rst with a 
short incubation time of 30 min and next with a long incubation time of 18 h. In addition, cells were fractionated into cytoplasmic and nuclear extracts to 
compare the proﬁ  les of the proteins that bind nonspeciﬁ  cally to the bead matrices. In the case of nuclear extracts, more proteins bind nonspeciﬁ  cally during 
a long incubation than a short incubation, as assessed both by Coomassie staining (B) and by mass spectrometric analysis (C). The cytoplasmic protein 
proﬁ  le did not vary to the same extent. The distribution of proteins by class was quite similar regardless of the cellular extract used in the experiment or 
the time of incubation (C). Distinct differences in the distribution of these classes of proteins were observed, however, with magnetic beads binding more 
cytoskeletal and structural proteins nonspeciﬁ  cally and Sepharose binding more nucleic acid binding factors nonspeciﬁ  cally.     JCB • VOLUME 183 • NUMBER 2 • 2008  232
SMN protein. This is important because not all proteins are ei-
ther functional or correctly expressed after tagging with GFP, 
and we thus wanted to test whether a similar workfl  ow could be 
applied for identifi  cation of protein partners using antibodies to 
endogenous proteins. For these experiments we used a mono-
clonal anti-SMN antibody (BD Biosciences), which was tested 
and found to specifi  cally immunoprecipitate SMN (see Fig. S3 
and Table S2, available at http://www.jcb.org/cgi/content/full/
jcb.200805092/DC1). A similar overall workfl  ow was applied, 
with minor modifications (see   Fig. 1 B  ). SILAC analysis of 
the immunoprecipitated proteins again identifi  ed many of the 
core SMN complex proteins, although the number of peptides 
and overall quality of the data were notably poorer than that 
obtained using the GFP binder and GFP-tagged SMN (Fig. S3 
and Table S2). One reason for this is likely the less effi  cient 
depletion of endogenous SMN by the anti-SMN mAb as com-
pared with the near-quantitative depletion of GFP-SMN using 
the GFP binder. It appears this is not simply a question of 
overall expression levels, however, as GFP-SMN is expressed 
in the stable cell line at a lower level than endogenous SMN 
(  Sleeman et al., 2003  ). To test this idea, we compared the 
data resulting from pull-down of GFP-SMN using the GFP 
binder with a pull-down using the commercial anti-GFP mAb 
previously shown to be less effi  cient in depletion of GFP (see 
  Fig. 2  ). The quality of the resulting data, including the number 
 affi  nity purifi  cation conditions in both cytoplasmic and nuclear 
extracts, and the nuclear extract  –  specifi  c enrichment of coilin 
(  Fig. 6 D  ). For comparison, sample mass spectra for SMN, U1A, 
and coilin peptides identifi  ed by SILAC analysis are shown 
(  Fig. 6 E  ). Although high SILAC ratios reliably distinguish 
binding specifi  city, we note that the absolute SILAC ratio cannot 
currently be used to infer stoichiometry of binding. As shown 
by the high standard deviation values measured for high SILAC 
ratios (see   Table III  , ratios   >  10 in bold), it is diffi  cult to accu-
rately quantitate ratio values when one of the components used 
to generate the ratio is present in very low amounts (see repre-
sentative peptide spectra in   Fig. 6 E  ). 
 After  confi  rming the positive identifi  cation of USP9X, we 
also tested by Western blotting other proteins that had high SILAC 
ratios yet were considered more likely to be contaminants based 
on the SILAC workfl  ow. For example, both desmin and transketo-
lase had high SILAC ratios in the cytoplasmic extract (  Fig. 5 B  ), 
but did not show specifi  c pull-down as judged by Western blotting 
(unpublished data). This confi  rms that they were indeed contami-
nants, most likely binding nonspecifi  cally to Sepharose beads. 
  SILAC analysis by direct 
immunoprecipitation 
  Finally, we also evaluated the SILAC method using direct 
immunoprecipitation with an antibody specifi  c for the endogenous 
Table III. Previously reported SMN interaction partners identiﬁ  ed in quantitative proteomics screen utilizing GFP binder to immunoprecipitate 
GFP-SMN complexes
MW (kD) Cytoplasmic
SILAC Ratio 
± SD
# Peptides Nucleoplasmic
SILAC Ratio 
± SD
# Peptides Reference
SMN 31.8   14.0 ± 19.0  15   76.4 ± 96.5  13 (  Kolb et al., 2007  ;   Otter et al., 2007  )
Gemin 2 31.6   10.8 ± 2.2  10   39.3 ± 26.8  6(   Liu et al., 1997  )
Gemin 3 92.2   74.2 ± 87.0  36   33.2 ± 35.6  33 (  Charroux et al., 1999  ;   Campbell et al., 2000  )
Gemin 4 120   66.5 ± 79.5  54   36.3 ± 46.8  46 (  Charroux et al., 2000  )
Gemin 5 168.6 5.2 ± 1.3 26 9.9 ± 7.3 19 (  Gubitz et al., 2002  )
Gemin 6 18.8   50.5 ± 59.8  7   34.3 ± 43.5  6(   Pellizzoni et al., 2002a  )
Gemin 7 14.5   36.8 ± 3.2  6   18 ± 12.1  5(   Baccon et al., 2002  )
Gemin 8 40.1   80.3 ± 102.3  11   26.1 ± 41.6  9(   Carissimi et al., 2006  )
U1A 31.3 3.5 ± 0.3 5 2.5 ± 0.2 4 (  Yong et al., 2002  )
SmB/B’ 30 0.8 ± 0.01 5 1.9 ± 0.1 5 (  Liu et al., 1997  ;   Pellizzoni et al., 2002b  )
SmD1 13.3 0.9 ± 0.1 6   11.4 ± 2.2  4(   Liu et al., 1997  ;   Pellizzoni et al., 2002b  )
SmD2 13.5 0.9 ± 0.1 10 8.9 ± 1.3 7 (  Liu et al., 1997  ;   Pellizzoni et al., 2002b  )
SmD3 13.9 1.0 ± 0.1 4 2.0 ± 0.2 5 (  Liu et al., 1997  ;   Pellizzoni et al., 2002b  )
SmE 10.8 1.0 ± 0.02 4 6.5 ± 0.6 4 (  Liu et al., 1997  ;   Pellizzoni et al., 2002b  )
SmF 9.7 1.0 ± 0.1 3 5.6 ± 0.03 4 (  Liu et al., 1997  ;   Pellizzoni et al., 2002b  )
SmG 8.5 1.0 ± 0.04 6 6.6 ± 1.4 4 (  Liu et al., 1997  ;   Pellizzoni et al., 2002b  )
Lsm10 14.1 5.8 ± 2.5 7 7.8 ± 2.7 5 (  Pillai et al., 2001  ,   2003  )
Lsm11 39.5 6.7 ± 1.7 11 0.7 ± 0.1 1 (  Pillai et al., 2003  )
Unrip 38.4 1.4 ± 0.1 11 3.6 ± 0.9 17 (  Carissimi et al., 2005  )
Coilin 62.6 - -   21.6 ± 13.0  14 (  Hebert et al., 2001  )
PRMT5 72.7 1.5 ± 0.3 5 - - (  Meister and Fischer, 2002  )
Fibrillarin 33.8 - - 2.8 ± 0.5 1 (  Liu and Dreyfuss, 1996  ;   Jones et al., 2001  ; 
   Pellizzoni et al., 2001a  )
hnRNP U 90.6 1.7 ± 0.1 8 3.9 ± 0.8 13 (  Liu and Dreyfuss, 1996  )
This table summarizes the protein interaction datasets collected from both cytoplasmic and nuclear extracts using the GFP binder to pull down GFP-SMN from stable HeLa 
cell lines. Both the SILAC ratio (with SD) and the number of peptides identiﬁ  ed for each protein in a particular experiment are indicated. Ratios >10, which inevitably show 
higher standard deviations, as discussed in the text, are in bold. References for the initial characterization of each protein as an SMN interaction partner are also listed.233 IDENTIFYING SPECIFIC PROTEIN INTERACTION PARTNERS   • Trinkle-Mulcahy et al. 
facilitate the reliable detection of bona fi  de protein interaction 
partners in cell extracts by immuno- and/or affi  nity purifi  cation. 
This approach has been made possible thanks to the recent 
  major advances in the sensitivity and mass accuracy of mass 
spectrometry  –  based proteomics (  Domon and Aebersold, 2006  ; 
  Cox and Mann, 2007  ). These technological improvements facili-
tate detection of lower abundance proteins and allow for a genu-
ine high-throughput approach. Increased sensitivity of detection 
alone does not reliably identify specifi  c interaction partners, 
however, as there is a concomitant detection also of the many 
nonspecifi  cally bound proteins that routinely copurify in pull-
down experiments. To minimize contaminants, many previous 
studies have used high stringency purifi  cation methods. This is 
of peptides identifi  ed and quantifi  ed, was clearly better using the 
GFP binder as compared with the commercial anti-GFP mAb 
(Fig. S3; Table S2). 
  In summary, these data show that the SILAC approach can 
be successfully applied for the analysis of endogenous proteins 
directly immunoprecipitated with antibodies. However, the overall 
quality of the resulting data will inevitably be affected by the 
specifi  city and effi  ciency of the available antibodies. 
  Discussion 
  This study describes a method based on quantitative SILAC 
mass spectrometry (  Ong et al., 2002  ) that has been optimized to 
  Figure 4.       Identiﬁ  cation of proteins that inter-
act with SMN and the SMN complex.   The GFP 
binder was used to immunopurify GFP-SMN 
from a stable HeLa cell line as compared with 
the nonexpressing parental cell line. Like en-
dogenous SMN, GFP-SMN is found in both 
cytoplasmic and nucleoplasmic pools and 
accumulates in gems within nuclei (A). Bar, 
15   μ  M. Detailed biochemical and proteomic 
studies have revealed that the core SMN com-
plex is composed of SMN itself and Gemins 
2  –  8 (B). The stoichiometry is not known and, 
although not depicted here, the complex can 
oligomerize. Also listed are several other 
proteins that have been shown to interact 
with the SMN complex by similar experimen-
tal approaches. In the study presented here, 
separate experiments were performed for cyto-
plasmic and nuclear extracts to independently 
assess interacting partners and compare these 
two pools. The log SILAC (i.e., heavy/light ar-
ginine and/or lysine) ratio calculated for each 
protein identiﬁ  ed in the cytoplasmic GFP-SMN 
immunoprecipitation experiment is plotted ver-
sus total peptide intensity in C. The nucleoplas-
mic GFP-SMN immunoprecipitation data are 
plotted in a similar fashion (D).     JCB • VOLUME 183 • NUMBER 2 • 2008  234
close to threshold values represent specifi  c interaction partners. 
This strategy can be applied directly to analyze endogenous pro-
tein complexes isolated by immunoprecipitation. In addition, 
we show that it can provide a powerful dual strategy when ap-
plied to the analysis of proteins interacting with GFP-tagged 
  fusion proteins in a   “  what you see is what you get  ”   approach. 
Importantly, this allows the integration of biochemical in vitro 
information derived from analysis of pull-down experiments, 
with in vivo data describing the localization, dynamics, and pro-
tein interactions derived from fl  uorescence microscopy. In con-
trast, the use of separate tags for affi  nity purifi  cation studies and 
microscopy analysis does not allow a direct comparison of the 
data obtained. GFP has been used previously as an affi  nity tag 
also not ideal because stringent purifi  cation procedures often 
result in the loss of specifi  c binding partners, for example those 
interacting in sub-stoichiometric amounts or binding with lower 
affi  nity. The strategy described here takes advantage of the 
sensitivity of modern mass spectrometry  –  based proteomics to 
identify en masse components of protein complexes purifi  ed 
under lower stringency conditions, which preserves more spe-
cifi  c interactions. 
  A key feature of the method involves combining SILAC 
ratios with bead proteomes and other data fi  ltering to distin-
guish likely specifi  c interacting proteins from the much larger 
pool of nonspecifi  c binding proteins (see   Fig. 5  ). This is particu-
larly valuable in assessing whether proteins with SILAC ratios 
  Figure 5.       Systematic analysis of SILAC data-
sets.   Quantitative mass spectrometric data 
generated by the cytoplasmic and nuclear GFP-
SMN immunoprecipitation experiments were 
subjected to a standard analysis workﬂ  ow. 
First, the frequency of speciﬁ  c SILAC (heavy/
light amino acid) ratios were plotted for the 
entire datasets to determine the distribution of 
these ratios among the proteins identiﬁ  ed (A). 
Environmental contaminants such as keratins 
have very low ratios and cluster near 0. In the 
cytoplasmic experiment, proteins that bind non-
speciﬁ  cally to the bead matrix cluster in a bell 
curve distribution around 1, as expected for 
proteins that bind equally in the light and heavy 
form. The threshold for detection of bona ﬁ  de 
interaction partners was set at a conservative 
level above that (hashed red line). Note that 
in the nuclear experiment the SILAC ratios for 
the bead contaminants were shifted to the left, 
clustering in a bell curve distribution around the 
higher value of 1.5. In this case the threshold 
(hashed blue line) must also be shifted. SMN 
itself, all of the core SMN complex members, 
and several known interacting partners fell 
above this threshold and were identiﬁ  ed in this 
ﬁ  rst analysis step. However, less abundant or 
lower afﬁ  nity binding partners may be found at 
or below these conservative threshold values. 
Analysis of the datasets is thus further extended 
by applying the Sepharose bead proteome as 
a ﬁ  lter and grouping the SILAC ratios of those 
proteins that have been identiﬁ  ed as binding 
nonspeciﬁ  cally to this bead matrix, as shown 
here for the cytoplasmic dataset (B). Most pro-
teins known to bind Sepharose (gray) and 
potential GFP-binding proteins (green) have 
the expected ratios near or below threshold, 
but a few are signiﬁ   cantly above threshold 
and must be considered as potentially real 
interacting proteins, albeit with a lower prior-
ity for further analysis. SILAC ratios calculated 
for the remaining proteins in the dataset, i.e., 
those not known to bind nonspeciﬁ  cally to ei-
ther the GFP tag or the bead matrix, are next 
plotted separately (C). Over two-thirds of the 
proteins have SILAC ratios signiﬁ  cantly higher 
than threshold. These include both known and 
novel interacting partners for SMN. Some of 
the known SMN complex interacting partners, 
such as PRMT5 and Unrip, have ratios closer to 
threshold, and thus would be overlooked in a 
threshold-based analysis. As expected for such 
a well-characterized complex, very few novel 
proteins were detected. One of these, USP9X, 
was selected for further analysis.     235 IDENTIFYING SPECIFIC PROTEIN INTERACTION PARTNERS   • Trinkle-Mulcahy et al. 
teins. Second, the recent advent of the GFP binder affi  nity probe 
allows near-quantitative depletion of GFP fusion proteins from 
cell extracts, thereby improving signal-to-noise ratios and max-
imizing the range of protein complexes that can be recovered. 
Based on the successful analysis of over 20 separate GFP fusion 
for proteomics studies (  Cristea et al., 2005  ;   Trinkle-Mulcahy 
et al., 2006  ). The results in this study underline the suitability of 
GFP as a dual strategy tag. First, both in vivo photobleaching 
experiments and SILAC mass spectrometry data show that GFP 
exhibits minimal nonspecifi  c binding to mammalian cell pro-
  Figure 6.       Validation of mass spectrometric results.   Cytoplasmic-speciﬁ  c copuriﬁ  cation of the novel protein USP9X with GFP-SMN was conﬁ  rmed by West-
ern blotting (A). Two peptides, each with a SILAC ratio   >  1, were found for USP9X in the SILAC analysis of a GFP-SMN pull-down from cytoplasmic extracts. 
The mass spectra of one of them is shown here for comparison (B). The quantiﬁ  able arginine is highlighted in red. This cytoplasmic enrichment of USP9X is 
consistent with immunostaining results using a monoclonal anti-USP9X antibody (C). Although predominantly cytoplasmic, there is a pool of USP9X in the 
nucleus (arrowhead), although it does not accumulate in gems (arrow). There is no difference in localization of USP9X in parental HeLa cells (top cell) versus 
HeLa cells stably expressing GFP-SMN (bottom cell). Bar, 5   μ  M. As a control, Western blotting was also used to conﬁ  rm the enrichment of both endogenous 
SMN and GFP-SMN, and of the U1 snRNP protein U1A, from both cytoplasmic and nuclear extracts using the GFP binder, and the nuclear-speciﬁ  c enrich-
ment of p80 coilin (D). For comparison, representative peptide spectra for these proteins from the SILAC analysis are shown (E). Quantiﬁ  able amino acids 
are highlighted in red, with the SILAC ratio in parentheses.     JCB • VOLUME 183 • NUMBER 2 • 2008  236
for cytoskeletal and structural proteins that are abundant in cyto-
plasmic extracts. Conversely, magnetic beads showed lower non-
specifi  c binding to nucleic acid  –  associated proteins and thus gave 
lower backgrounds than either Sepharose or agarose when used 
with nuclear extracts. These data provide objective grounds for 
concluding that no single type of affi  nity matrix is best for all 
purposes, and highlights the importance of choosing the most 
suitable combination of reagents based on the specifi  c details of 
the experiment to be performed. 
  An important question raised by this identifi  cation of many 
proteins that clearly bind nonspecifi  cally to commonly used af-
fi  nity matrices in protein  –  protein interaction experiments is the 
accuracy of the published literature. In many cases, published 
studies have listed as potential interaction partners proteins shown 
here to bind nonspecifi  cally to affi  nity matrices. The bead pro-
teome fi  lters thus provide a useful and objective resource that can 
be consulted by cell biologists to help avoid expending time and 
effort on the analysis of proteins that may prove to be simple con-
taminants. In the future, accumulating information from many 
laboratories on the range of nonspecifi  c protein interactions 
observed using different cell types, extracts, tags, and affi  nity 
matrices will provide an invaluable resource and we propose this 
should be established as a freely accessible online database. 
  In summary, the present data show that a strategy combin-
ing SILAC analysis with bead proteome fi  ltering and enhanced 
data analysis procedures can reliably be used to characterize 
specifi  c protein interaction partners while using isolation proce-
dures that preserve the binding of lower abundance and lower 
affi  nity proteins. We show that this can also resolve interaction 
events confi  ned to either nuclear or cytoplasmic compartments. 
Inevitable differences in the biochemical properties of different 
proteins mean that no unique isolation protocol may be ideal in 
every case. Nonetheless, we could show that a similar isolation 
protocol could be successfully applied to analyze over 20 dif-
ferent GFP fusion proteins in multiple different cell extracts and 
from two separate mammalian cell lines. Even when precise 
isolation conditions must be varied, our data indicate general 
principles that apply, including the importance of maintaining 
short incubation times during affi  nity purifi  cation and the need 
to optimize the overall effi  ciency of affi  nity depletion. We show 
the strategy can be used for the analysis of tagged or endogenous 
complexes and thus conclude it provides a general approach 
that can be widely applied for the analysis of protein binding 
partners in different fi  elds of cell biology. 
  Materials and methods 
  Tissue culture 
  HeLa 
EGFP   and HeLa 
EGFP-SMN   stable cell lines were obtained and character-
ized as described previously (  Sleeman et al., 2003  ). Cells were grown in 
custom-made DMEM (minus arginine and lysine; Invitrogen) supplemented 
with 10% dialyzed fetal calf serum (Invitrogen) and penicillin/streptomy-
cin (Invitrogen). The selection marker G418 was added to SILAC media 
used with stable cell lines expressing GFP-tagged proteins. For double 
encoding experiments,   L  -arginine (84   μ  g/ml; Sigma-Aldrich) and   L-  lysine 
(146   μ  g/ml lysine; Sigma-Aldrich) were added to the   “  light  ”   media, 
while   L  -arginine  
13  C and   L  -lysine  
13  C (Cambridge Isotope Laboratory) 
were added to the   ”  heavy  ”   media at the same concentrations. For triple 
encoding experiments,   L  -arginine and   L  -lysine were added to the   “  light  ”  , 
  L  -arginine  
13  C and   L  -lysine 4,4,5,5-D4 (Cambridge Isotope Laboratory) to 
proteins in whole cell, cytoplasmic, and nuclear extracts, our 
results indicate that a similar strategy can be readily applied for 
the analysis of interaction partners binding to most, if not all, 
GFP-tagged proteins. 
  In the SILAC-based strategy for analyzing protein inter-
action partners (see   Fig. 1  ), the ratio of heavy to light isotopes 
measured for each peptide detected provides an unbiased and 
often clear-cut index for distinguishing specifi  c from nonspe-
cifi  c binding proteins (for examples of peptide spectra, see   Fig. 6  ). 
In some cases, however, particularly for lower abundance pro-
teins, the  
13 C/ 
12  C (SILAC) ratio alone is not suffi  cient to unambig-
uously distinguish specifi  city. The order of steps in the workfl  ow 
and the detailed experimental protocol can be sources of vari-
ability. For example, accurately controlling the amounts of ma-
terial mixed together before or after immunoprecipitation can 
affect the ratio. In addition, the ratio can also be affected by 
dissociation of proteins from the complex during isolation. 
Depending on the complex under study, it could also happen 
that exchange occurs between the isotope-labeled proteins on 
the affi  nity matrix and proteins in the control extract (  Wang and 
Huang, 2008  ). For these reasons, our results show it is impor-
tant to minimize the binding time whenever possible, which 
will also help to reduce the level of nonspecifi  c protein binding. 
This latter point is illustrated by the larger cohort of nonspecifi  c 
binding proteins recovered after extended (18 h) incubation of 
the extracts with all three affinity matrices (see Fig. S2 and 
  Table S1). Finally, it is also important to optimize the effi  ciency 
of protein pull-down. This is best illustrated by the comparison 
of using a commercial anti-GFP mAb as compared with GFP 
binder to affi  nity purify GFP-SMN (see Fig. S3 and Table S2). 
  As illustrated here by the analysis of the well-characterized 
SMN complex, a useful additional criterion to add to the SILAC 
ratio is to fi  lter all identifi  ed proteins against a database of pro-
teins found to bind nonspecifi  cally to affi  nity matrices under a 
range of conditions. This was shown to help distinguish known 
SMN interaction partners from likely contaminants (see   Table III   
and   Fig. 5  ). In the case of Sepharose, the bead proteome was 
derived from 27 different SILAC-based pull-down experiments. 
This includes separate analysis for pull-downs performed in 
whole cell, nuclear, and cytoplasmic extracts for both HeLa 
and U2OS cell lines. Identical results were obtained for both cell 
lines and the data have therefore been combined in the Sepha-
rose bead proteome presented (  Tables I and II  ). Interestingly, 
similar sets of protein contaminants were identifi  ed in the sepa-
rate cytoplasmic and nuclear extracts, including ribosomal, heat 
shock, hnRNP, and intermediate fi  lament proteins. We extended 
the analysis of the bead proteome to include direct comparisons 
of Sepharose, agarose, and magnetic beads, which to the best 
of our knowledge currently represent the three most commonly 
used affi  nity matrices. Unexpectedly, differences were observed 
in the spectrum of contaminating proteins that predominate for 
each of these matrices, and this varied between the separate nu-
clear and cytoplasmic extracts. Thus, we did not observe a single 
bead matrix that gave universally lower levels of contaminants 
under all circumstances. For cytoplasmic extracts, the lowest 
background levels were obtained using either Sepharose or agarose. 
Magnetic beads, in contrast, showed more nonspecifi  c binding 237 IDENTIFYING SPECIFIC PROTEIN INTERACTION PARTNERS   • Trinkle-Mulcahy et al. 
anti-U1A (856 rabbit polyclonal, 1:2,000 WB), anti-desmin (Abcam mAb; 
1:500 WB), and anti-transketolase (goat polyclonal, 1:500; Santa Cruz 
Biotechnology, Inc.). HRP-conjugated secondary antibodies (Thermo Fisher 
Scientiﬁ  c) were detected using the ECL-Plus reagent (GE Healthcare). 
  For the endogenous SMN immunoafﬁ  nity experiment and the bead 
proteome experiment comparing Protein G  –  Agarose (GE Healthcare), Pro-
tein G  –  Sepharose (GE Healthcare), and the magnetic Protein G  –  Dynabeads 
(Invitrogen), equivalent total protein amounts of extracts were incubated 
separately on the appropriate matrices and combined carefully after one 
wash step in RIPA buffer. After a further three wash steps in RIPA buffer, 
bound proteins were eluted and subjected to 1D SDS/PAGE followed by 
band excision and peptide digestion as described above. 
  Mass spectrometry and data analysis 
  An aliquot of the tryptic digest (prepared in 5% acetonitrile/0.1% triﬂ  uoro-
acetic acid in water) was analyzed by LC-MS on an LTQ-Orbitrap mass 
spectrometer system (ThermoElectron) coupled to a Dionex 3000 nano-LC 
system (Camberley). The peptide mixture was loaded onto an LC-Packings 
PepMap C18 column trap column (0.3   ×   5 mm) equilibrated in 0.1% TFA 
in water at 20   μ  l/min, washed for 3 min at the same ﬂ  ow rate, and then 
the trap column was switched in-line with an LC-Packings PepMap C18 
column (0.075   ×   150 mm) equilibrated in 0.1% formic acid/water. 
The peptides were separated with a 55-min discontinuous gradient of ace-
tonitrile/0.1% formic acid (2  –  40% acetonitrile for 40 min) at a ﬂ  ow rate 
of 300 nl/min and the HPLC interfaced to the mass spectrometer with 
an FS360-20-10 picotip (New Objective) ﬁ  tted to a nanospray 1 interface 
(ThermoElectron) with a voltage of 1.1 kV applied to the liquid junction. 
  The Orbitrap was set to analyze the survey scans at 60,000 resolu-
tion and the top ﬁ  ve ions in each duty cycle selected for MSMS in the LTQ 
linear ion trap. The raw ﬁ  les were processed to generate a Mascot generic 
ﬁ   le using the program Raw2msm (  Olsen et al., 2005  ) and searched 
against the UniProt human database using the Mascot search engine v.2.2 
(Matrix Science) run on an in-house server using the following criteria; 
peptide tolerance = 10 ppm, trypsin as the enzyme and carboxyamido-
methylation of cysteine as a ﬁ  xed  modiﬁ   cation. Variable modiﬁ  cations 
were oxidation of methionine, medium SILAC labels were: Label  
13  C(6) (R), 
Label  
2  H(4) (K), and heavy SILAC labels were: label  
13  C(6)  
15  N (4)(R), 
label  
13  C(4)  
15  N (2) (K). 
  Quantitation was performed using the program MS-Quant (http://
msquant.sourceforge.net), with peptide ratios calculated for each arginine- 
and/or lysine-containing peptide as the peak area of labeled arginine/ 
lysine divided by the peak area of nonlabeled arginine/lysine for each 
single-scan mass spectrum. Peptide ratios for all arginine- and lysine-
containing peptides sequenced for each protein were averaged. Individual 
spectra were inspected using QualBrowser software (XCalibur; Thermo-
Electron). ProteinCenter (Proxeon Bioinformatics) proteomics data mining 
and management software was used to eliminate redundancy and com-
pare datasets, and to convert protein IDs to gene symbols and perform initial 
Gene Ontology characterization. 
  Fluorescence microscopy and photobleaching experiments 
  Fluorescence imaging was performed on a DeltaVision Spectris wideﬁ  eld 
deconvolution microscope (Applied Precision) ﬁ  tted with an environmental 
chamber (Solent Scientiﬁ  c) to maintain temperature at 37  °  C, a CoolMax 
charge-coupled device camera (Roper Scientiﬁ  c) and a quantiﬁ  able laser 
module (QLM; Applied Precision) with a 488-nm laser. For ﬁ  xed cell imag-
ing, a mix of parental HeLa cells and HeLa cells stably expressing GFP-SMN 
were paraformaldehyde ﬁ  xed on glass coverslips, permeabilized with Tri-
ton X-100, stained with both anti-USP9X (detected by TRITC-anti  –  mouse sec-
ondary antibodies) and the DNA stain DAPI, and mounted in FluorSave 
mounting media (Calbiochem). Cells were imaged using a 60x NA 1.4 Plan-
Apochromat objective (Olympus) and the appropriate ﬁ  lter sets (Chroma 
Technology Corp.), with 20 optical sections of 0.5   μ  M each acquired. Soft-
WorX software (Applied Precision) was used for both acquisition and de-
convolution. For the FRAP experiments, HeLa cells stably expressing free 
GFP were cultured in glass-bottomed dishes (WILLCO, Intracel) and mounted 
on the same system. A single section was imaged before photobleaching, a 
region of interest was then bleached to     50% of its original intensity using 
the 488-nm laser, and a rapid series of images was acquired after the photo-
bleach period. Recovery curves were plotted and the mobile fraction and 
half time of recovery were determined using SoftWorx. 
  Online supplemental material 
  Table S1 contains a comprehensive list of all proteins identiﬁ  ed in the com-
parative bead proteome SILAC experiment, including separate datasets for 
the   “  medium  ”  , and   L  -arginine  
13  C/ 
15  N and   L  -lysine  
13  C/ 
15  N (Cambridge 
Isotope Laboratory) to the   ”   heavy  ”   media. The amino acid concentra-
tions are based on the formula for normal DMEM (Invitrogen). Once pre-
pared, the SILAC media was mixed well, ﬁ  ltered through a 0.22-  μ  m ﬁ  lter 
(Millipore) using a suction pump, and stored at 4  °  C. HeLa and U2OS cell 
lines were passaged in SILAC media for at least 5  –  6 cell doublings be-
fore harvesting to ensure complete incorporation of isotopic amino acids 
(  Ong and Mann, 2007  ;   Harsha et al., 2008  ). PBS-based nonenzymatic 
cell dissociation buffer (Invitrogen) was used to passage cells, as trypsin-
EDTA solutions may contain amino acids. 
  Preparation of cellular extracts 
  Whole cell extracts were prepared by solubilizing trypsinized and pelleted 
cells in ice-cold RIPA buffer (50 mM Tris, pH 7.5, 150 mM NaCl, 1% NP-
40, 0.5% deoxycholate, and protease inhibitors), sonicating brieﬂ  y on ice 
(5   ×   10 s at full power), and clearing extracts by centrifuging at 2,800   g   
(3,500 rpm, GH3.8 rotor; Beckman Coulter GS-6) for 10 min at 4  °  C. For 
preparation of cytoplasmic and nuclear fractions, 10   ×   14-cm dishes of 
cells were trypsinized and pelleted, resuspended in 5 ml of ice-cold swell-
ing buffer (10 mM Hepes, pH 7.9, 1.5 mM MgCl  2  , 10 mM KCl, 0.5 mM 
DTT, and protease inhibitors) for 5 min, and cells were broken open to re-
lease nuclei using a pre-chilled Dounce homogenizer (20 strokes with a 
tight pestle). Dounced cells were centrifuged at 228   g   (1,000 rpm, GH-3.8 
rotor; Beckman Coulter GS-6) for 5 min at 4  °  C to pellet nuclei and other 
fragments. The supernatant was retained as the cytoplasmic fraction. 
Before use, 1 ml of 5x RIPA buffer was added and clearing performed as 
described above. The nuclear pellet was resuspended in 3 ml of 0.25 M 
sucrose/10 mM MgCl  2   and layered over a 3-ml cushion of 0.88 M 
  sucrose/0.5 mM MgCl  2   and centrifuged at 2,800   g   (3,500 rpm, GH-3.8 
rotor; Beckman Coulter GS-6) for 10 min at 4  °  C. The resulting cleaner nu-
clear pellet was resuspended in 5 ml of RIPA buffer, sonicated and cleared 
as described above. Total protein concentrations were measured using a 
Bradford assay. 
  Immunoafﬁ  nity puriﬁ  cation of GFP-tagged and endogenous proteins 
  Monoclonal anti-GFP antibodies (Roche) were covalently coupled to pro-
tein G  –  Sepharose beads (GE Healthcare) at 2 mg/ml. The beads were 
incubated with antibody for 1 h at 4  °  C and then washed twice with 10 vol-
umes of 0.1 M sodium borate, pH 9. Next, the beads were incubated with 
10 volumes of borate buffer containing 20 mM dimethylpimelimidate 
(DMP; Sigma-Aldrich) for 30 min at room temperature. The beads were 
pelleted and resuspended with 10 volumes of freshly prepared 20 mM 
DMP in borate buffer for an additional 30-min incubation. The beads were 
washed twice with 10 volumes of ice-cold 50 mM glycine (pH 2.5) to re-
move unbound antibody and then washed several times with PBS or RIPA 
buffer for use and/or storage at 4  °  C. Monoclonal anti-SMN antibodies (BD 
Biosciences) were covalently coupled to protein G  –  Sepharose at 1 mg/ml 
using a similar protocol. GFP binder (ChromoTek) was prepared and cova-
lently coupled to NHS-activated Sepharose 4 Fast Flow beads (GE Health-
care) at 1 mg/ml as described previously (  Rothbauer et al., 2008  ). 
  For the GFP immunoafﬁ  nity experiments, extracts from each cell line 
were precleared by incubation on Sepharose beads alone for 30 min at 
4  °  C and then mixed in a 1:1 ratio based on total protein concentration. 
GFP alone or GFP-SMN were afﬁ  nity puriﬁ  ed by incubation with either 
anti-GFP mAbs or GFP binder conjugated to Sepharose beads. Incubation 
times varied according to the antibody and the experiment, and we recom-
mend a maximum 1-h incubation, if possible. The afﬁ   nity matrix was 
washed four times with RIPA buffer. To ensure efﬁ  cient elution of bound pro-
teins, a bead-equivalent volume of 1% SDS was added, the matrix boiled 
for 10 min and then a 4x volume of dH  2  O added. The matrix was vortexed 
and the solution removed and reduced to the original bead-equivalent volume 
(and 1% SDS concentration) using a speedvac. Proteins were reduced 
and alkylated in this solution, ﬁ  rst by the addition of 10 mM DTT (boil 
for 2 min), and then the addition of 50 mM iodoacetamide (incubate at 
room temperature in the dark for 30 min). A small aliquot of Laemmli 
sample buffer was added and proteins were separated by running halfway 
down NuPAGE 12% Bis-Tris gels. Gels were Coomassie stained and de-
stained overnight before excision of slices. Peptides resulting from in-gel 
digestion with trypsin (Promega) were extracted from the gel slices for 
automated LC-MS/MS analysis. For validation of SILAC results, GFP and 
GFP-SMN were afﬁ  nity puriﬁ  ed separately using the GFP binder and sub-
jected to 1D SDS/PAGE and Western blotting. Primary antibodies used for 
Western blotting (and immunoﬂ  uorescence, where indicated) included anti-
USP9X (AbCam mAb, 1:500 WB, 1:50 IF), anti-coilin (204/10 rabbit 
polyclonal, 1:1,000 WB), anti-SMN (BD Biosciences mAb, 1:1,000 WB), JCB • VOLUME 183 • NUMBER 2 • 2008  238
cytosolic and nuclear extracts and for 30-min and 18-h incubations. Pref-
erential enrichment on either Sepharose or magnetic beads is indicated 
and commonly found keratins are listed separately. Table S2 compares the 
quality of data obtained for known SMN complex members using either 
GFP binder or mAb anti-GFP to afﬁ  nity purify GFP-SMN and mAb anti-
SMN to afﬁ  nity purify endogenous SMN. Fig. S1 demonstrates the rapid 
recovery of free GFP in both the cytoplasm and nucleoplasm after photo-
bleaching in live cells. Fig. S2 compares the distribution of nonspeciﬁ  c 
protein binding between Sepharose and agarose and between magnetic 
beads and agarose. Fig. S3 graphically compares data obtained us-
ing either GFP binder or mAb anti-GFP to afﬁ  nity purify GFP-SMN and 
mAb anti-SMN to afﬁ  nity purify endogenous SMN. Coomassie gels used 
to separate proteins before mass spectrometric analysis are shown, and 
SILAC ratio vs. total peptide abundance plotted for known SMN complex 
members. Online supplemental material is available at http://www.jcb
.org/cgi/content/full/jcb.200805092/DC1. 
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